MRK vs MA
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
MRK · Merck & Co$146.73 ▼ 0.14%
MA · MasterCard$652.70 ▼ 0.49%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- MRK +73.1%
- MA +18.6%
Head to head
| Metric | MRK | MA |
|---|---|---|
| Price | $146.73 | $652.70 |
| Change today | ▼ 0.14% | ▼ 0.49% |
| Market cap | $361.73B | $568.62B |
| Return, 3 months | +12.1% | +15.9% |
| Return, year to date | +41.4% | +14.9% |
| Return, 1 year | +74.0% | +18.8% |
| P/E (TTM) | 148.2 | 34.2 |
| P/B | 8.1 | 84.2 |
| P/E percentile vs own 5y | 95th | 20th |
| Dividend yield | 2.32% | 0.52% |
| Revenue growth (YoY, latest qtr) | +4.7% | +14.0% |
| Net profit growth (YoY) | -12.4% | +17.9% |
| Gross margin | 71.8% | 78.4% |
| Operating margin | 9.2% | 60.1% |
| Net margin | 3.6% | 46.7% |
| Return on equity | – | 231.4% |
| Analyst target vs. price | +14.1% | +10.0% |
| Analyst buy share | 79% | 92% |
| RSI (14) | 51 | 64 |
| 30-day volatility | 33.2% | 26.3% |
| Max drawdown, 1 year | -11.4% | -18.5% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- MA is the largest of the group by market value.
- MRK has returned the most over the past year.
- MA carries the lowest trailing P/E.
- MRK pays the highest dividend yield.
- MA is growing revenue fastest.
- MA keeps the most profit per dollar of sales.
- MA has been the calmest stock over the last 30 days.